Hai-Juan Zhi, Yi Ding, Yu-Xin Deng, Ting Chen, Yue Cao, Si-Yu Chang, Xia Zhan, Feng Xu, Li-Li Hao, Li-Li Liang, Wen-Juan Qiu, Hui-Wen Zhang, Xue-Fan Gu, Lian-Shu Han
Xinhua Hospital, Shanghai Institute for Pediatric Research, Shanghai Jiaotong University School of Medicine.
China
American Chemical Society Omega
ACS Omega 2026; 11: 56235-56250
DOI: 10.1021/acsomega.6c06980
Abstract
Methylmalonic acidemia (MMA) is a rare recessively inherited disorder mainly caused by variants in the MMUT and MMACHC genes, leading to the accumulation of methylmalonic acid. The pathophysiological mechanisms of MMA remain poorly understood, and treatments are symptomatic. This study investigated the comprehensive metabolic remodeling signatures of the MMA subtypes. We applied targeted metabolomics to dried blood spot (DBS) samples obtained from a Chinese cohort of 85 patients, consisting of 42 MUT-MMA, 23 CblC-MMA, and an additional 20 CblC-MMA presenting kidney injury and pulmonary arterial hypertension (PAH) as the initial symptoms. In addition, metabolite alterations were also assessed following treatments adopting a reduction analysis. The targeted metabolomics study highlighted the presence of significant differences among the MMA subtypes. New biomarkers (carbohydrates and short-chain fatty acids) were proposed for MUT, while novel data regarding the alterations of unsaturated fatty acid profiles and biomarkers of phenylalanine, tyrosine, and tryptophan biosynthesis were obtained for CblC disease. We also revealed the metabolic remodeling signatures in MMA patients following treatment. Additionally, key differences were identified between the CblC-MMA-presenting kidney injury and PAH populations, particularly regarding phenylacetylglutamine and isovalerylcarnitine, which may serve as discriminatory biomarkers for these subtypes. These findings provide a robust metabolic framework that facilitates precise subtype diagnosis, therapeutic monitoring, and a mechanistic understanding of MMA heterogeneity.
Category
Class I. Heritable Pulmonary Hypertension
Genetic Factors Associated with Pulmonary Vascular Disease
Potential Biomarkers Associated with Pulmonary Vascular Disease
Age Focus: Pediatric Pulmonary Vascular Disease
Fresh or Filed Publication: Fresh (PHresh). Less than 1-2 years since publication
Article Access
Free PDF File or Full Text Article Available Through PubMed or DOI: Yes